News

Category:

Dewpoint

February 13, 2023

Targeting biomolecular condensates: A novel opportunity in drug discovery presented at KEYSTONE SYMPOSIA on Heart Development and Disease: From Genes to Cures

Jeanette Bressi

VP, Head of Communications & PR
Dewpoint Therapeutics
+1 609-439-3997 | jbressi@dewpointx.com

Scott Peterson, Ph.D.

SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com

Back to News home section

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA

Condensates.com